205 related articles for article (PubMed ID: 24890202)
1. Relapsing-remitting severe generalized muscular weakness after botulinum toxin treatment for hyperhidrosis.
Chiarello D; Piombo M; Corbetto M; Di Pino G; Assenza G; Capone F; Di Lazzaro V
Muscle Nerve; 2014 Sep; 50(3):456-7. PubMed ID: 24890202
[No Abstract] [Full Text] [Related]
2. Generalized neurological symptoms following treatment of focal hyperhidrosis with botulinum toxin A.
Kouris A; Agiasofitou E; Gregoriou S; Sofouri E; Kontochristopoulos G; Panagopoulos G
Int J Dermatol; 2014 Nov; 53(11):e544-7. PubMed ID: 25209010
[No Abstract] [Full Text] [Related]
3. Muscle weakness in treatment of palmar hyperhidrosis with botulinum toxin type a: can it be prevented?
Kouris A; Vavouli C; Markantoni V; Kontochristopoulos G
J Drugs Dermatol; 2014 Nov; 13(11):1315-6. PubMed ID: 25607695
[TBL] [Abstract][Full Text] [Related]
4. Writer's block: "texting" impairment as a complication of botulinum toxin type A therapy for palmar hyperhidrosis.
Lehman JS
Arch Dermatol; 2011 Jun; 147(6):752. PubMed ID: 21690551
[No Abstract] [Full Text] [Related]
5. Systemic effect of local and small-dose botulinum toxin injection to unmask subclinical myasthenia gravis.
Iwase T; Iwase C
Graefes Arch Clin Exp Ophthalmol; 2006 Mar; 244(3):415-6. PubMed ID: 16175373
[No Abstract] [Full Text] [Related]
6. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months.
Frasson E; Brigo F; Acler M; Didonè G; Vicentini S; Bertolasi L
Arch Dermatol; 2011 Jan; 147(1):122-3. PubMed ID: 21242408
[No Abstract] [Full Text] [Related]
7. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
[TBL] [Abstract][Full Text] [Related]
8. Contralateral weakness following botulinum toxin for poststroke spasticity.
Thomas AM; Simpson DM
Muscle Nerve; 2012 Sep; 46(3):443-8. PubMed ID: 22907238
[TBL] [Abstract][Full Text] [Related]
9. Systemic adverse effects after botulinum toxin type B (myobloc) injections for the treatment of palmar hyperhidrosis.
Baumann LS; Halem ML
Arch Dermatol; 2003 Feb; 139(2):226-7. PubMed ID: 12588237
[No Abstract] [Full Text] [Related]
10. Inverse psoriasis and hyperhidrosis of the axillae responding to botulinum toxin type A.
Saber M; Brassard D; Benohanian A
Arch Dermatol; 2011 May; 147(5):629-30. PubMed ID: 21576592
[No Abstract] [Full Text] [Related]
11. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
Rosell K; Hymnelius K; Swartling C
Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
[TBL] [Abstract][Full Text] [Related]
12. Myaesthenia gravis exacerbation caused by axillary injection of botulinum toxin A for treatment of hyperhidrosis.
El-Heis S; Burke G; Gibb W; Ardern-Jones MR
Clin Exp Dermatol; 2017 Apr; 42(3):357-359. PubMed ID: 28111784
[No Abstract] [Full Text] [Related]
13. Treatment of compensatory hyperhidrosis with botulinum toxin type A.
Belin EE; Polo J
Cutis; 2003 Jan; 71(1):68-70. PubMed ID: 12553633
[TBL] [Abstract][Full Text] [Related]
14. Treatment of axillary hyperhidrosis with botulinum-A toxin.
Salmanpoor R; Rahmanian MJ
Int J Dermatol; 2002 Jul; 41(7):428-30. PubMed ID: 12121560
[TBL] [Abstract][Full Text] [Related]
15. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
Lowe N; Campanati A; Bodokh I; Cliff S; Jaen P; Kreyden O; Naumann M; Offidani A; Vadoud J; Hamm H
Br J Dermatol; 2004 Dec; 151(6):1115-22. PubMed ID: 15606505
[TBL] [Abstract][Full Text] [Related]
16. Long-term Safety and Dosing of OnabotulinumtoxinA: A Prospective, Observational Study.
Wein T; Jog M; Bhogal M; Dhani S; Miller R; Ismail F; Beauchamp R; Trentin G
Can J Neurol Sci; 2019 Nov; 46(6):742-752. PubMed ID: 31256770
[TBL] [Abstract][Full Text] [Related]
17. Treatment of palmar hyperhidrosis with botulinum neurotoxin a.
Mannava S; Mannava KA; Nazir OF; Plate JF; Smith BP; Koman LA; Tuohy CJ
J Hand Surg Am; 2013 Feb; 38(2):398-400. PubMed ID: 23267759
[No Abstract] [Full Text] [Related]
18. Hyperhidrosis of face and scalp: repeated successful treatment with botulinum toxin type A.
Komericki P; Ardjomand N
Indian J Dermatol Venereol Leprol; 2012; 78(2):201-2. PubMed ID: 22421660
[No Abstract] [Full Text] [Related]
19. How to save botulinum toxin A in the treatment of focal axillary hyperhidrosis.
Bechara FG; Sand M; Hoffmann K
Dermatology; 2006; 213(4):356. PubMed ID: 17135747
[No Abstract] [Full Text] [Related]
20. Problems with botulinum toxin treatment in mitochondrial cytopathy: case report and review of the literature.
Gioltzoglou T; Cordivari C; Lee PJ; Hanna MG; Lees AJ
J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1594-6. PubMed ID: 16227561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
